Nantahala Capital Management’s Aura Biosciences AURA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $13.3M | Buy |
2,117,697
+850,000
| +67% | +$5.32M | 0.52% | 30 |
|
|
2025
Q1 | $7.43M | Sell |
1,267,697
-2,338
| -0.2% | -$13.7K | 0.3% | 43 |
|
|
2024
Q4 | $10.4M | Hold |
1,270,035
| – | – | 0.45% | 40 |
|
|
2024
Q3 | $11.3M | Hold |
1,270,035
| – | – | 0.57% | 28 |
|
|
2024
Q2 | $9.6M | Sell |
1,270,035
-51,825
| -4% | -$392K | 0.56% | 28 |
|
|
2024
Q1 | $10.4M | Hold |
1,321,860
| – | – | 0.59% | 27 |
|
|
2023
Q4 | $11.7M | Buy |
1,321,860
+577,968
| +78% | +$5.12M | 0.7% | 24 |
|
|
2023
Q3 | $6.67M | Sell |
743,892
-59,433
| -7% | -$533K | 0.57% | 33 |
|
|
2023
Q2 | $9.92M | Sell |
803,325
-40,121
| -5% | -$495K | 0.96% | 24 |
|
|
2023
Q1 | $7.83M | Buy |
843,446
+44,695
| +6% | +$415K | 0.6% | 33 |
|
|
2022
Q4 | $8.39M | Buy |
798,751
+414,987
| +108% | +$4.36M | 0.54% | 32 |
|
|
2022
Q3 | $6.95M | Buy |
383,764
+40,549
| +12% | +$735K | 0.45% | 38 |
|
|
2022
Q2 | $4.86M | Buy |
343,215
+41,225
| +14% | +$584K | 0.24% | 48 |
|
|
2022
Q1 | $6.64M | Buy |
301,990
+202,844
| +205% | +$4.46M | 0.29% | 47 |
|
|
2021
Q4 | $1.68M | Buy |
+99,146
| New | +$1.68M | 0.06% | 87 |
|